Formulation Development

Products

Information

We develop phase-appropriate formulations for liquid, frozen and lyophilized drug products, focusing on your target product profile (TPP) and designing the study to meet your requirements. Our offering includes: - Preformulation Screening - Preclinical Formulation Development - Formulation Transfer - Clinical Phase I and II Formulation Development - Late-Phase Clinical and Commercial Formulation Development

All Categories

PeptidesInjectablesBiopharmaceuticals (General Category)BiosimilarsAntibodiesDrug Formulation (general category)Antibody Drug Conjugates (ADCs)Cell & Gene therapyAntiinfectives for Systemic useInjectable systems and components

Main Categories

Biopharmaceutical ProductsFinished Dosage Forms (Products)Packaging Materials and Equipment (Products)Innovative APIsPharmaceutical Machinery & Technology (Products)Anatomical Therapeutic Chemical (ATC) Classification Products

Coriolis Pharma Research GmbHCoriolis Pharma is a globally operating contract research and development organization (CRDO) and the premier partner for drug product development, analytical, and manufacturing services across a vast array of therapeutic modalities, including antibodies, peptides, therapeutic proteins, cell and gene therapy, nucleic acids and more. We focus on liquid and lyophilized drug products and provide our services under both, R&D and GMP conditions. Our expert scientists design and execute our platform and custom services to accelerate and derisk your path to market.

Formulation Development

Information

Log in